News & Updates
Filter by Specialty:
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
byElvira Manzano
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023S-ketamine anaesthesia improves recovery following modified radical mastectomy
12 Jul 2023
byNatalia Reoutova
A prospective randomized controlled trial of breast cancer (BC) patients undergoing modified radical mastectomy (MRM) finds that S-ketamine used in place of sufentanil for general anaesthesia (GA) improves postoperative recovery.
S-ketamine anaesthesia improves recovery following modified radical mastectomy
12 Jul 2023Newly diagnosed glaucoma ups risk of dementia
03 Jul 2023
The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.